Dr. Richard Soll, WuXi’s Senior Vice President of International Discovery Service Unit, was recently interviewed by BioWorld at the 2014 International BIO Convention in San Diego.  In the interview, Richard discussed WuXi’s vision and platforms including our manufacture of a sterile biologics that reportedly received the first FDA approval for such product manufactured in China under a U.S. IND.  He also talked about the new International Discovery Service Unit that he is spearheading.  “WuXi is devoted to the service sector,” said Richard.  “What we do is to enable global innovation.”




Related links:

First Chinese-made biologics slated for human trials in the West
WuXi’s YouTube Channel